These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 3247706)

  • 21. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M
    Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anorexia nervosa and Raynaud's phenomenon: a case report.
    Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J
    Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medical treatment of Raynaud's syndrome].
    Larbre JP; Nicolas JF; Larbre B; Perret-Liaudet P; Adam C; Thivolet J
    Rev Med Interne; 1988; 9(4):429-34. PubMed ID: 3065874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases].
    Kumagai S; Morinobu A; Ozaki S; Nakao K; Ishida H
    Ryumachi; 1998 Jun; 38(3):504-10. PubMed ID: 9721558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Raynaud's phenomenon and connective tissue diseases].
    Guilmot JL; Diot E; Lasfargues G; Boissier C
    Rev Prat; 1998 Oct; 48(15):1647-52. PubMed ID: 9814065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
    Smith CD; McKendry RJ
    Lancet; 1982 Dec; 2(8311):1299-301. PubMed ID: 6128596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Raynaud's phenomenon and calcium blocking agents. A preliminary open study with flunarizine].
    Centonze V; Campanale G; Vino M; Caporaletti P; Magrone D; Russo P; Di Bari M; Loragno V; Albano O
    Clin Ter; 1991 Apr; 137(2):77-82. PubMed ID: 1828407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T; Hartling OJ; Kelbaek H; Nielsen SL
    Eur J Clin Pharmacol; 1986; 31(4):387-9. PubMed ID: 3816916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-angiotensin system mediators and Raynaud's phenomenon.
    Wood HM; Ernst ME
    Ann Pharmacother; 2006 Nov; 40(11):1998-2002. PubMed ID: 17003081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Calcium antagonists in the treatment of Raynaud's syndrome and in the treatment of esophageal spasm].
    Kahan A; Amor B; Menkès CJ
    Rev Prat; 1988 Nov; 38(27):1986-8. PubMed ID: 3206151
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.
    Torley HI; Madhok R; Capell HA; Brouwer RM; Maddison PJ; Black CM; Englert H; Dormandy JA; Watson HR
    Ann Rheum Dis; 1991 Nov; 50(11):800-4. PubMed ID: 1722967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of longterm nifedipine in a patient with Raynaud's syndrome secondary to mixed connective tissue disease.
    Sarkozi J; McCarthy DD; Lee P
    J Rheumatol; 1984 Jun; 11(3):408-10. PubMed ID: 6737386
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
    Varela-Aguilar JM; Sánchez-Román J; Talegón Meléndez A; Castillo Palma MJ
    Rev Clin Esp; 1997 Feb; 197(2):77-83. PubMed ID: 9213861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.